Empfehlung
12,4
Stark Verkaufen
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
41.8
6 neu, 3 erhöht, -7644K $ netto
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Stammdaten
Unternehmen
| Name | YD Bio Ltd |
|---|---|
| Ticker | YDES |
| CIK | 0002011674 |
Branche
| SIC-Code | 8071 |
|---|---|
| Beschreibung | Services-Medical Laboratories |
Wertpapier
| CUSIP | G98301107 |
|---|---|
| ISIN | USG983011077 |
| Typ | Common Stock |
| Titel | YD BIO LTD |
Status
| Zuletzt geprüft | 2026-03-20 12:49:40.820682 |
|---|
Fondsaktivität (letzte 3 Quartale)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| Cypress Capital Management LLC (WY) | 4,476,198 | 4,269,686 | 206,512 | 4,739,884 | Aufgestockt | +4,8% | |
| Cerity Partners LLC | 343,995 | 0 | 343,995 | 1,294,630 | Neu | +100,0% | |
| Oasis Management Co Ltd. | 100,000 | 100,000 | 0 | 1,219,000 | Unverändert | 0,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 58,363 | 53,071 | 5,292 | 711,444 | Aufgestockt | +10,0% | |
| Clear Street Group Inc. | 94,158 | 108,530 | -14,372 | 93,216 | Reduziert | -13,2% | |
| UBS Group AG | 7,564 | 10,316 | -2,752 | 88,038 | Reduziert | -26,7% | |
| Merit Financial Group, LLC | 40,000 | 40,000 | 0 | 39,600 | Unverändert | 0,0% | |
| WOLVERINE ASSET MANAGEMENT LLC | 2,516 | 18,134 | -15,618 | 30,670 | Reduziert | -86,1% | |
| CITIGROUP INC | 1,709 | 0 | 1,709 | 20,833 | Neu | +100,0% | |
| ARISTEIA CAPITAL, L.L.C. | 13,274 | 13,274 | 0 | 13,606 | Unverändert | 0,0% | |
| MORGAN STANLEY | 299 | 10,257 | -9,958 | 3,645 | Reduziert | -97,1% | |
| BNP PARIBAS FINANCIAL MARKETS | 90 | 0 | 90 | 1,752 | Neu | +100,0% | |
| HRT FINANCIAL LP | 31,819 | 0 | 31,819 | 619 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 409 | 304 | 105 | 461 | Aufgestockt | +34,5% | |
| FMR LLC | 1 | 1 | 0 | 12 | Unverändert | 0,0% | |
| SUMMIT SECURITIES GROUP LLC | 1 | 0 | 1 | 1 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Fail-to-Deliver (6 Monate)
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-02-24 | 9 | 8,13 | 73 |
| 2026-02-18 | 697 | 8,68 | 6.050 |
| 2026-02-17 | 557 | 9,99 | 5.564 |
Top-Fondshalter (aktuelles Quartal)
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| Cypress Capital Management LLC (WY) | 4,476,198 | 4,739,884 | 68.10 |
| Oasis Management Co Ltd. | 100,000 | 1,219,000 | 17.51 |
| GEODE CAPITAL MANAGEMENT, LLC | 58,363 | 711,444 | 10.22 |
| Clear Street Group Inc. | 94,158 | 93,216 | 1.34 |
| UBS Group AG | 7,564 | 88,038 | 1.26 |
| Merit Financial Group, LLC | 40,000 | 39,600 | 0.57 |
| WOLVERINE ASSET MANAGEMENT LLC | 2,516 | 30,670 | 0.44 |
| CITIGROUP INC | 1,709 | 20,833 | 0.30 |
| ARISTEIA CAPITAL, L.L.C. | 13,274 | 13,606 | 0.20 |
| MORGAN STANLEY | 299 | 3,645 | 0.05 |
| BANK OF AMERICA CORP /DE/ | 409 | 461 | 0.01 |
| FMR LLC | 1 | 12 | 0.00 |
| SUMMIT SECURITIES GROUP LLC | 1 | 1 | 0.00 |